Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

Jörge E. Cortes, Carlo B Gambacorti-Passerini, Michael W. Deininger, Michael J. Mauro, Charles T. H. Chuah, Dong‐Wook Kim and 11 more

Rank
50 of 667
Percentile
top 7.5%
Where
Journal of Clinical Oncology, 2017
Citations
495

From the 2017 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.